Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
2 | |
| 03/31/10 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
66 | |
| 01/21/10 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
54 | |
| 09/09/09 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
54 | |
| 03/06/09 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
51 | |
| 07/01/08 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
81 | |
| 03/31/08 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
81 | |
| 04/02/07 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
46 | |
| 10/20/06 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
38 | |
| 09/20/06 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
36 |
